Sugi Predict

Sugi Predict / Compounds / Carnitine

Carnitine

Carnitine

SCHEMBL28275398

CC(O)CC(=O)O.C[N+](C)(C)CC(O)CC(=O)[O-]

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC22A16 Q86VW1 1/20 0.74
▸ MAPT P10636 2/20 0.62
▸ CPT2 P23786 2/20 0.48
▸ CPT1A P50416 2/20 0.48
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ HRH1 P35367 1/20 0.43
▸ CRAT P43155 1/20 0.43
▸ CYP2C19 P33261 2/20 0.41
▸ RECQL P46063 1/20 0.41
▸ LMNA P02545 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ CA2 P00918 1/20 0.39
▸ SLC22A6 Q4U2R8 1/20 0.38
▸ TP53 P04637 2/20 0.36
▸ CYP2D6 P10635 2/20 0.36
▸ TSHR P16473 2/20 0.36
▸ SLC25A20 O43772 2/20 0.36
▸ CPT1B Q92523 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Carnitine SCHEMBL28290852 0.89 SLC22A16 (0.74) SLC22A16MAPTCPT2CPT1AMEN1
Carnitine SCHEMBL27574253 0.86 SLC22A16 (0.91) SLC22A16MAPTCPT2CPT1AMEN1
Carnitine SCHEMBL29036059 0.86 SLC22A16 (0.91) SLC22A16MAPTCPT2CPT1AMEN1
D-Carnitine SCHEMBL94286 0.86 SLC22A16 (1.00) SLC22A16MAPTCPT2CPT1AMEN1
Carnitine SCHEMBL21971 0.86 SLC22A16 (1.00) SLC22A16MAPTCPT2CPT1AMEN1
Levocarnitine SCHEMBL21970 0.86 SLC22A16 (1.00) SLC22A16MAPTCPT2CPT1AMEN1
Carnitine SCHEMBL3902633 0.86 SLC22A16 (1.00) SLC22A16MAPTCPT2CPT1AMEN1
Carnitine SCHEMBL1813524 0.86 SLC22A16 (1.00) SLC22A16MAPTCPT2CPT1AMEN1
Carnitine SCHEMBL17629811 0.86 SLC22A16 (1.00) SLC22A16MAPTCPT2CPT1AMEN1
Levocarnitine SCHEMBL4593172 0.86 SLC22A16 (1.00) SLC22A16MAPTCPT2CPT1AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117191963-A Biomarkers, systems, and uses thereof for predicting whether progression to ACLF or mortality in ACLF patients will occur 上海甘宁医疗科技有限公司 2023-12-08 — — CN claimed
CN-109394744-A It is a kind of to include L-carnitine-beta-hydroxy-butanoic acid salt composition and preparation method 博瑞生物医药（苏州）股份有限公司 2019-03-01 — — CN claimed
CN-117191963-A Biomarkers, systems, and uses thereof for predicting whether progression to ACLF or mortality in ACLF patients will occur 上海甘宁医疗科技有限公司 2023-12-08 — — CN disclosed
CN-112341331-B 3-hydroxybutyrate and preparation method and application thereof 辽宁科硕营养科技股份有限公司 2023-04-07 — — CN disclosed
CN-112341331-A 3-hydroxybutyrate and preparation method and application thereof 辽宁科硕营养科技股份有限公司 2021-02-09 — — CN disclosed
CN-109394744-A It is a kind of to include L-carnitine-beta-hydroxy-butanoic acid salt composition and preparation method 博瑞生物医药（苏州）股份有限公司 2019-03-01 — — CN disclosed
CN-109394745-A A kind of composition comprising L-carnitine and beta-hydroxy-butanoic acid compound 博瑞生物医药（苏州）股份有限公司 2019-03-01 — — CN disclosed
CN-109394745-A A kind of composition comprising L-carnitine and beta-hydroxy-butanoic acid compound 博瑞生物医药（苏州）股份有限公司 2019-03-01 — — CN disclosed
CN-109394744-A It is a kind of to include L-carnitine-beta-hydroxy-butanoic acid salt composition and preparation method 博瑞生物医药（苏州）股份有限公司 2019-03-01 — — CN disclosed
CN-109394744-A It is a kind of to include L-carnitine-beta-hydroxy-butanoic acid salt composition and preparation method 博瑞生物医药（苏州）股份有限公司 2019-03-01 — — CN disclosed
Send feedback